Stockscreener 앱 받기
1.5105
3.13%
-0.0495
전일 마감가:
$1.56
열려 있는:
$1.56
하루 거래량:
585.52K
Relative Volume:
0.25
시가총액:
$1.20B
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-7.95
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
-3.13%
1개월 성능:
+7.18%
6개월 성능:
+11.12%
1년 성능:
+2.80%
1일 변동 폭
$1.5112
$1.57
1주일 범위
$1.5112
$1.60
52주 변동 폭
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
OPK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.515 | 1.24B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
528.08 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
204.45 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
618.94 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
137.40 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
201.27 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
OPKO Health (NASDAQ:OPK) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Smart tools for monitoring OPKO Health Inc.’s price actionJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Real time pattern detection on OPKO Health Inc. stock2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
NextPlat Issues CEO Shareholder Update Letter - Benzinga
OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
OPKO acquiring company from Barcelona - Law.com
Can machine learning forecast OPKO Health Inc. recoveryPortfolio Return Summary & Safe Entry Zone Identification - newser.com
How OPKO Health Inc. stock performs in weak economyJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
Why OPKO Health Inc. stock attracts global investorsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Technical signs of recovery in OPKO Health Inc.July 2025 Highlights & Fast Moving Market Watchlists - newser.com
How OPKO Health Inc. (XCY) stock reacts to stronger dollarJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
How to manage a losing position in OPKO Health Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Ranking OPKO Health Inc. among high performing stocks via toolsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What institutional flow reveals about OPKO Health Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
OPKO Health (OPK): Valuation Insights as Clinical Pipeline Progress and Asset Sales Draw Investor Focus - Sahm
Washington Growth Strategies LLC Has $1.79 Million Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and CEO Boosts Stake Has the Bull Case Changed? - Sahm
Why OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and Notable Insider Buying - Sahm
Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN
What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance
What analysts say about OPKO Health Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
12 Healthcare Stocks with Insider Buying in 2025 - Insider Monkey
OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - MSN
Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis Farma - Barchart.com
44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance
Opko Health, Inc. (OPK) Stock Analysis: Unlocking a Potential 151% Upside with Strategic Healthcare Innovations - DirectorsTalk Interviews
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Lowers Position in OPKO Health, Inc. $OPK - MarketBeat
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
0.22%
0.74%
자본화:
|
볼륨(24시간):